Baseline 10-year cardiovascular risk scores predict cognitive function in older persons, and particularly women, living with HIV infection.

BACKGROUND Cardiovascular disease (CVD) and associated comorbidities increase the risk of cognitive impairment in persons living with HIV (PLWH). Given the potential composite effect of multiple cardiovascular risk factors on cognition, we examined the ability of the Atherosclerotic Cardiovascular Disease (ASCVD) risk score and the Framingham Heart Study Global CVD risk score (FRS) to predict future cognitive function in older PLWH. METHODS We constructed linear regression models evaluating the association between baseline 10-year CV risk scores and cognitive function (measured by NPZ-4 score) at a Year 4 follow up visit. RESULTS Among 988 participants (mean age 52 years, 20% women), mean 10-year ASCVD risk score at entry into the cohort was 6.8% (SD 7.1%) and FRS was 13.1% (SD 10.7%). In models adjusted only for cognitive function at entry, the ASCVD risk score significantly predicted Year 4 NPZ-4 in the entire cohort and after stratification by sex (for every 1% higher ASCVD risk, Year 4 NPZ-4 was lower by 0.84 SD +/- 0.28 overall, p=0.003; lower by 2.17 SD +/- 0.67 in women, p=0.001; lower by 0.78 SD +/- 0.32 in men, p=0.016). A similar relationship was observed between FRS and Year 4 NPZ-4. In multivariable models, higher 10-year ASCVD risk and FRS predicted lower NPZ-4 in women. CONCLUSION Baseline 10-year ASCVD risk and FRS predicted future cognitive function in older PLWH with well-controlled infection. CV risk scores may help to identify individuals, especially women, living with HIV who are at risk for worse cognition over time.

[1]  L. Wilkins.  Comparing the acute presentation of sport-related concussion in the adult and pediatric populations , 2019, Neurology.

[2]  J. Zissimopoulos,et al.  Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States , 2018, Alzheimer's & dementia.

[3]  R. Ellis,et al.  Physical Activity Is Associated With Lower Odds of Cognitive Impairment in Women but Not Men Living With Human Immunodeficiency Virus Infection , 2018, The Journal of infectious diseases.

[4]  R. D'Agostino,et al.  Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection , 2018, Circulation.

[5]  L. Fellows,et al.  Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection , 2017, Journal of acquired immune deficiency syndromes.

[6]  Owen Carmichael,et al.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV , 2017, Journal of NeuroVirology.

[7]  P. Reiss,et al.  Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy , 2016, AIDS.

[8]  A. Hoepelman,et al.  Cardiovascular risk prediction in HIV‐infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE‐NL) and Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) risk prediction models , 2016, HIV medicine.

[9]  Mardge H. Cohen,et al.  Human immunodeficiency virus (HIV) modulates the associations between insulin resistance and cognition in the current combination antiretroviral therapy (cART) era: a study of the Women’s Interagency HIV Study (WIHS) , 2015, Journal of NeuroVirology.

[10]  I. Grant,et al.  Abdominal Obesity Contributes to Neurocognitive Impairment in HIV-Infected Patients With Increased Inflammation and Immune Activation , 2015, Journal of acquired immune deficiency syndromes.

[11]  D. Lacaille,et al.  2013 ACC/AHA guideline on the assessment of cardiovascular risk. , 2014, Journal of the American College of Cardiology.

[12]  M. Pletcher,et al.  Cardiovascular Risk Score, Cognitive Decline, and Dementia in Older Mexican Americans: The Role of Sex and Education , 2013, Journal of the American Heart Association.

[13]  I. Grant,et al.  Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder , 2012, Neurology.

[14]  C. Moy,et al.  Vascular risk factors and cognitive impairment in a stroke-free cohort , 2011, Neurology.

[15]  L. McEvoy,et al.  Sex Differences in the Association of Framingham Cardiac Risk Score With Cognitive Decline in Community-Dwelling Elders Without Clinical Heart Disease , 2011, Psychosomatic medicine.

[16]  M. Kivimäki,et al.  Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study , 2011, European heart journal.

[17]  W. El-Sadr,et al.  Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons , 2010, Neurology.

[18]  Sudha Seshadri,et al.  Association of MRI Markers of Vascular Brain Injury With Incident Stroke, Mild Cognitive Impairment, Dementia, and Mortality: The Framingham Offspring Study , 2010, Stroke.

[19]  J. Becker,et al.  Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men , 2009, Neurology.

[20]  C. Noel Bairey Merz,et al.  Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.

[21]  P. Sachdev,et al.  Sex differences in the causes and consequences of white matter hyperintensities , 2009, Neurobiology of Aging.

[22]  E. V. van Dijk,et al.  Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.

[23]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[24]  O. Selnes,et al.  Insulin Resistance Is Associated With Cognition Among HIV-1-Infected Patients: The Hawaii Aging With HIV Cohort , 2006, Journal of acquired immune deficiency syndromes.

[25]  Niels D Prins,et al.  Cerebral small-vessel disease and decline in information processing speed, executive function and memory. , 2005, Brain : a journal of neurology.

[26]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[27]  R B D'Agostino,et al.  Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.

[28]  Sudha Seshadri,et al.  Framingham Stroke Risk Profile and Lowered Cognitive Performance , 2004, Stroke.

[29]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[30]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[31]  A. Hofman,et al.  Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2002, Stroke.

[32]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[33]  J Tuomilehto,et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study , 2001, BMJ.

[34]  L. Fried,et al.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. , 1996, Stroke.

[35]  Bonnie K. Lind,et al.  Infarctlike lesions in the brain: prevalence and anatomic characteristics at MR imaging of the elderly--data from the Cardiovascular Health Study. , 1997, Radiology.

[36]  K. Langa,et al.  Title: Framingham Stroke Risk Profile and Poor Cognitive Function: a Population-based Study , 2022 .